Immunocore Holdings (IMCR) Exchange Rate Effect (2023 - 2026)
Immunocore Holdings' (IMCR) quarterly Exchange Rate Effect came in at -$6.1 million in Q1 2026, down 172.8% year-on-year from $8.4 million in Q1 2025, and down 322.16% quarter-over-quarter from -$1.5 million in Q4 2025.
Immunocore Holdings (IMCR) Exchange Rate Effect (2023 - 2026) Analysis & Trends
Immunocore Holdings has disclosed Exchange Rate Effect across 4 years of filings, most recently posting -$6.1 million for Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at -$6.1 million, down 172.8% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.1 million (up 60.93% YoY), and the FY2025 annual result was $26.7 million, up 1660.83% from the prior year.
- Exchange Rate Effect came in at -$6.1 million for Q1 2026 at Immunocore Holdings, down from -$1.5 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $12.3 million in Q3 2024 to a low of -$13.0 million in Q4 2024.
- The 4-year median for Exchange Rate Effect is $2.2 million (2023), against an average of $2.1 million.
- Across the five-year window, Exchange Rate Effect slumped 220.86% in 2024 and soared 7564.15% in 2025, its largest moves.
- Immunocore Holdings' Exchange Rate Effect stood at $10.8 million in 2023, then plunged by 220.86% to -$13.0 million in 2024, then jumped by 88.85% to -$1.5 million in 2025, then tumbled by 322.16% to -$6.1 million in 2026.
- The last three Exchange Rate Effect figures came in at -$6.1 million (Q1 2026), -$1.5 million (Q4 2025), and $7.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 2 | Belite Bio | 55,234.00 Bn | 55,234.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,823.14 Bn | 17,823.14 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,624.50 Bn | 3,624.21 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,745.73 Bn | 1,745.73 Bn | - | - |
| 6 | Evaxion A | 1,540.85 Bn | 1,540.84 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.57 Bn | 105.33 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 93.46 Bn | 93.46 Bn | - | 8.68 Mn |
| 10 | Immunocore Holdings | 1.46 Bn | 616.35 Mn | 106.24 Mn | -6.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.13 Mn |
| Mar 31, 2026 | -6.13 Mn |
| Dec 31, 2025 | -1.45 Mn |
| Dec 31, 2025 | -1.45 Mn |
| Sep 30, 2025 | 7.82 Mn |
| Sep 30, 2025 | 7.82 Mn |
| Jun 30, 2025 | 11.87 Mn |
| Jun 30, 2025 | 11.87 Mn |
| Mar 31, 2025 | 8.43 Mn |
| Mar 31, 2025 | 8.43 Mn |
| Dec 31, 2024 | -13.03 Mn |
| Dec 31, 2024 | -13.03 Mn |
| Sep 30, 2024 | 12.29 Mn |
| Sep 30, 2024 | 12.29 Mn |
| Jun 30, 2024 | -159,000.00 |
| Jun 30, 2024 | -159,000.00 |
| Mar 31, 2024 | -800,000.00 |
| Mar 31, 2024 | -800,000.00 |
| Dec 31, 2023 | 10.78 Mn |
| Dec 31, 2023 | 10.78 Mn |